These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 29140067)

  • 21. FDA marketing v. First Amendment: Washington Legal Foundation legal challenges to off-label policies may force unprecedented changes at FDA.
    Kamp J; Troy DE; Alexander E
    Food Drug Law J; 1999; 54(4):555-65. PubMed ID: 11824453
    [No Abstract]   [Full Text] [Related]  

  • 22. First Amendment limits on regulating information: an initial reaction to the Washington Legal Foundation case.
    Gibbs JN
    Food Drug Law J; 1998; 53(4):597-601. PubMed ID: 10557578
    [No Abstract]   [Full Text] [Related]  

  • 23. The Food and Drug Administration's regulation of prescription drug manufacturer speech: a First Amendment analysis.
    Evans GW; Friede AI;
    Food Drug Law J; 2003; 58(3):365-437. PubMed ID: 14626984
    [No Abstract]   [Full Text] [Related]  

  • 24. United States v. Caronia: Off-Label Drug Promotion and First Amendment Balancing.
    Rabinowitz DP
    Fordham Law Rev; 2018 Apr; 86(5):2595-623. PubMed ID: 29993225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A global view of the First Amendment constraints of FDA.
    Carver KH
    Food Drug Law J; 2008; 63(1):151-215. PubMed ID: 18561459
    [No Abstract]   [Full Text] [Related]  

  • 26. The First Amendment and the Food and Drug Administration's regulation of labeling and advertising: three proposed reforms.
    Kahan JS; Shapiro JK
    Food Drug Law J; 2003; 58(3):353-64. PubMed ID: 14626983
    [No Abstract]   [Full Text] [Related]  

  • 27. The impact of Wyeth v. Levine on FDA regulation of prescription drugs.
    Ausness RC
    Food Drug Law J; 2010; 65(2):247-83, i-ii. PubMed ID: 24475542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Commentary: can we talk? About Food and Drug Regulation and the First Amendment.
    Cohen MN
    Food Drug Law J; 2003; 58(4):741-56. PubMed ID: 15027458
    [No Abstract]   [Full Text] [Related]  

  • 29. Handwriting Evidence in Federal Courts - From Frye to Kumho.
    Zlotnick J; Lin JR
    Forensic Sci Rev; 2001 Jul; 13(2):87-99. PubMed ID: 26256304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The FDA's graphic tobacco warnings and the first amendment.
    Orentlicher D
    N Engl J Med; 2013 Jul; 369(3):204-6. PubMed ID: 23803137
    [No Abstract]   [Full Text] [Related]  

  • 31. The FDA and graphic cigarette-pack warnings--thwarted by the courts.
    Bayer R; Johns D; Colgrove J
    N Engl J Med; 2013 Jul; 369(3):206-8. PubMed ID: 23803139
    [No Abstract]   [Full Text] [Related]  

  • 32. The butt stops here: the Tobacco Control Act's anti-smoking regulations run afoul of the First Amendment.
    Weatherby D; Day TR
    Albany Law Rev; 2012-2013; 76(1):121-65. PubMed ID: 23577376
    [No Abstract]   [Full Text] [Related]  

  • 33. Drug manufacturers' First Amendment right to advertise and promote their products for off-label use: avoiding a pyrrhic victory.
    Blackwell AE; Beck JM;
    Food Drug Law J; 2003; 58(3):439-62. PubMed ID: 14626985
    [No Abstract]   [Full Text] [Related]  

  • 34. Is state power to protect health compatible with substantive due process rights?
    Jacobs AJ
    Ann Health Law; 2011; 20(1):113-49, 7 p preceding 1. PubMed ID: 21639020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Smoking and the First Amendment.
    Outterson K
    N Engl J Med; 2011 Dec; 365(25):2351-3. PubMed ID: 22149735
    [No Abstract]   [Full Text] [Related]  

  • 36. Guide to preemption of state-law claims against Class III PMA medical devices.
    Whitney DW
    Food Drug Law J; 2010; 65(1):113-39, ii-iii. PubMed ID: 24475536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prescription data mining, medical privacy and the First Amendment: the U.S. Supreme Court in Sorrell v. IMS health Inc.
    Boumil MM; Dunn K; Ryan N; Clearwater K
    Ann Health Law; 2012; 21(2):447-91, 4 p preceding i. PubMed ID: 22606922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. "It's time to make a good agency better": the Food and Drug Administration Modernization Act of 1997 and the First Amendment.
    Murphy AM
    Food Drug Law J; 1998; 53(4):603-25. PubMed ID: 10557579
    [No Abstract]   [Full Text] [Related]  

  • 39. The First Amendment and FDA restrictions on off-label uses: the call for a new approach.
    Leghorn J; Brophy E; Rother P
    Food Drug Law J; 2008; 63(2):391-406. PubMed ID: 18561466
    [No Abstract]   [Full Text] [Related]  

  • 40. Over-the-counter human drugs; labeling requirements; final rule; technical amendment. Food and Drug Administration, HHS. Final rule; technical amendment.
    Fed Regist; 2000 Jan; 65(1):7-9. PubMed ID: 11010625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.